| Product NDC: | 59011-255 |
| Proprietary Name: | Intermezzo |
| Non Proprietary Name: | zolpidem tartrate |
| Active Ingredient(s): | 3.75 mg/1 & nbsp; zolpidem tartrate |
| Administration Route(s): | SUBLINGUAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59011-255 |
| Labeler Name: | Purdue Pharma LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022328 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120405 |
| Package NDC: | 59011-255-05 |
| Package Description: | 5 CARTON in 1 TRAY (59011-255-05) > 1 POUCH in 1 CARTON > 1 TABLET in 1 POUCH |
| NDC Code | 59011-255-05 |
| Proprietary Name | Intermezzo |
| Package Description | 5 CARTON in 1 TRAY (59011-255-05) > 1 POUCH in 1 CARTON > 1 TABLET in 1 POUCH |
| Product NDC | 59011-255 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zolpidem tartrate |
| Dosage Form Name | TABLET |
| Route Name | SUBLINGUAL |
| Start Marketing Date | 20120405 |
| Marketing Category Name | NDA |
| Labeler Name | Purdue Pharma LP |
| Substance Name | ZOLPIDEM TARTRATE |
| Strength Number | 3.75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE] |